Paul Berns

Paul Berns

Directeur Général chez NEUMORA THERAPEUTICS, INC.

Fortune : 14 M $ au 30/06/2026

59 ans
Health Technology
Finance
Process Industries

Profil

Paul L.
Berns
founded HIBio, Inc. in 2021, where he worked as Chairman from 2021 to 2024 and Neumora Therapeutics, Inc. in 2019, where he is working as Chairman & Chief Executive Officer from 2025.
Mr. Berns also founded Ollin Biosciences, Inc., where he is working as Executive Chairman, Salma Health, Inc., where he is working as Director, and Tenvie Therapeutics, Inc., where he is working as Executive Chairman.
Mr. Berns also currently works at Happy Ai Software, Inc., as Chairman, Human Immunology Biosciences, Inc., as Chairman from 2021, ARCH Venture Partners LLC, as Managing Director, and various other companies.
Mr. Berns also formerly worked at Bone Care International, Inc., as President, Chief Executive Officer & Director from 2002 to 2005, Allos Therapeutics, Inc., as President, Chief Executive Officer & Director from 2006 to 2012, Anacor Pharmaceuticals LLC, as Chairman, President & Chief Executive Officer from 2014 to 2016, and various other companies.
Mr. Berns received his undergraduate degree from the University of Wisconsin.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/04/2026 7 708 851 ( 4,16 % ) 13 M $ 30/06/2026
0,02 %
22/06/2026 20 706 ( 0,02 % ) 493 838 $ 30/06/2026

Postes actifs de Paul Berns

SociétésPosteDébut
NEUMORA THERAPEUTICS, INC. Directeur Général 14/02/2025
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 07/09/2022
Directeur/Membre du Conseil 01/01/2020
Directeur/Membre du Conseil 01/08/2019

Anciens postes connus de Paul Berns

SociétésPosteFin
UNITY BIOTECHNOLOGY, INC. Directeur/Membre du Conseil 04/04/2025
Fondateur 01/07/2024
EQRX, INC. Directeur/Membre du Conseil 09/11/2023
JAZZ PHARMACEUTICALS PLC Directeur/Membre du Conseil 29/07/2021
Voir l'expérience en détail de Paul Berns

Formation de Paul Berns

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées28

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Paul Berns
🔇